President Trump claims his tariffs could finance a $2000 dividend for Americans, but experts raise serious doubts about the feasibility and legality of this plan. Is it a smart move or just political rhetoric?
President Trump has announced a proposal to pay each American a $2,000 dividend funded by tariff revenue. However, Treasury Secretary Bessent has raised doubts about the feasibility of this plan, suggesting it may just be tax savings.
The U.S. Supreme Court's skepticism on Trump's tariffs has traders re-evaluating their chances, with market optimism rising as major indexes rebound. But what if the court demands refunds? Find out the potential implications for stocks and tariffs!
Asian stocks experienced a rise driven by optimism from the U.S.-China trade truce and increased AI spending. However, uncertainty looms over the longevity of the truce as investors reassess their strategies.
The Federal Reserve has approved its second consecutive interest rate cut, but Chair Jerome Powell's uncertain comments about future reductions have rattled markets. With inflation still above target, what does this mean for consumers and the economy?
The Nikkei 225 index has crossed the 50,000 mark for the first time, fueled by positive U.S.-China trade talks and a booming Wall Street. With Japan's Prime Minister meeting President Trump, domestic demand may see a significant boost, lifting Japan out of stagnation. Discover how this impacts global markets!
Apple's upcoming iOS 26.4 is set to introduce a revamped Siri, but early testing reveals concerns about its performance. With ongoing delays and internal doubts, can Apple deliver a truly intelligent assistant?
A major shareholder in Core Scientific is set to reject the proposed $5 billion acquisition by rival CoreWeave, raising doubts about one of 2023's largest data center mergers. Trip Miller of Gullane Capital argues the deal undervalues Core Scientific, while CoreWeave defends it as a strategic move. The upcoming vote on October 30 could reshape the future of both companies amidst growing investor concerns.
The Black Phone 2 struggles to capture the horror of its predecessor, failing to deliver a compelling narrative or memorable scares. With convoluted plot twists and an uninspired villain, this sequel may leave fans disappointed.
In a stunning development, federal prosecutors investigating James Comey face significant hurdles as a key witness contradicts allegations against him, raising doubts about the case's viability.